EP
Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ·Healthcare·Biotechnology
$6.01
-1.48%
Mkt Cap $222.64M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (1 analysts)
$19.00
Range $19.00 – $19.00
Implied Upside
+216.1%
Consensus $19.00 vs current $6.01
NASDAQ·Healthcare·Biotechnology
$6.01
-1.48%
Mkt Cap $222.64M
Buy
3
Hold
0
Sell
0
Price Target (1 analysts)
$19.00
Range $19.00 – $19.00
+216.1%
Consensus $19.00 vs current $6.01